Screener
Apogee Therapeutics, Inc. APGE Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215698
| Line item | THREE MONTHS ENDEDMARCH 31, 2026 | THREE MONTHS ENDEDMARCH 31, 2025 |
|---|---|---|
| Other income, net: | ||
| Interest income, net | 8,740 | 7,840 |
| Total other income, net | 8,740 | 7,840 |
| Net loss before taxes | (74,032) | (55,256) |
| Provision for income taxes | (79) | (83) |
| Net loss after taxes | $(74,111) | $(55,339) |
| Net loss per share, basic and diluted | $(1.06) | $(0.95) |
| Weighted-average common shares outstanding, basic and diluted | 69,668,439 | 58,195,272 |
Item 6. [Exhibits](#item_6_exhibits) [71](#item_6_exhibits)
FAQ
- What is Apogee Therapeutics, Inc.'s net income?
- Apogee Therapeutics, Inc. (APGE) reported net income of -$74.11M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s net income changed year-over-year?
- Apogee Therapeutics, Inc.'s net income decreased by 33.9% year-over-year, from -$55.34M to -$74.11M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s net income?
- Over 3 years (2022 to 2025), Apogee Therapeutics, Inc.'s net income has grown at a 57.4% compound annual growth rate (CAGR), from -$65.56M to -$255.84M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Apogee Therapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude